Olivier Loeillot sold $977K of Repligen (RGEN)

Executed Sep 21, disclosed Sep 22, 1 day later.

Value, as filed

$977K

5,426 sh × $180.00

Executed

Sep 21

the trade date, as filed

Disclosed

Sep 22

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Olivier Loeillot Chief Executive Officer profile →

Olivier Loeillot (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Repligen Corporation (RGEN). The largest single filing was $1.2M of RGEN (7,041 sh × $170.00, as filed), executed Nov 25 2025.

The name

RGEN

Repligen Corporation RGEN · Healthcare · 17 filings in 24 months ticker →

Healthcare · Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Olivier Loeillot in RGEN

RGENSALE Repligen Corporation $504K
3,035 sh × $165.90
Exec Sep 4
Filed Sep 8 · 4:13 PM ET RGENSALE Repligen Corporation $977K
5,426 sh × $180.00
Exec Aug 20
Filed Aug 21 · 4:06 PM ET RGENSALE Repligen Corporation $536K
3,832 sh × $140.00
Exec Apr 21
Filed Apr 22 · 5:30 PM ET RGENSALE Repligen Corporation $1.2M
7,041 sh × $170.00
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET